Purpose: Robot-assisted laparoscopic partial nephrectomy (RLPN) is gaining acceptance as an alternative to open partial nephrectomy and laparoscopic partial nephrectomy for small renal masses. However, it still remains a technically challenging procedure even for experienced laparoscopists. Endophytic tumors or renal hilar tumors pose an additional challenge.
INTRODUCTION
Nephron-sparing surgery is now considered the standard of care for small renal tumors (＜4 cm) [1] . Partial nephrectomy [3] . Another option is the use of laparoscopic radical nephrectomy. Issues such as adequacy of resection, vascular [4] .
Robotics application thus makes nephron-sparing surgery feasible for complex tumors. We present our initial outcomes in 11 successfully conducted RLPN cases.
MATERIALS AND METHODS

Subjects
From September 2006 to March 2009, RLPN was performed in a total of 52 cases by a single surgeon. Eleven of these were for complex renal tumors (endophytic or hilar) (Fig. 1 ). Table   1 shows the patients' demographic data. In imaging studies taken before the operation, all of the tumors were considered to be confined to the kidney. All operations were conducted transperitoneally with the Da Vinci Ⓡ surgical system. One patient was diagnosed with chronic renal failure. The serum creatinine level was 2.3 mg/dl. All other patients had normal renal function of both kidneys.
Surgical technique
1) Position and port placement:
The patient was positioned with some modifications to the conventional lumbotomy position [4] . Pneumoperitoneum was established by using the Veress needle just above the umbilicus. A 12 mm camera port was placed in its place. Three 8 mm robot instrument ports were placed as was done by Park et al ( Fig. 2 ) [4] . An optional 5 mm assistant port was placed subxiphoid when deemed necessary.
2) Ultrasound and tumor exposure: Bowel and kidney mobilization was done in the usual manner [4] . By using the robotic scissors and bipolar forceps, the renal vein and renal artery were exposed to complete mobilization of the kidney.
Gerota's fascia was dissected on the area of the tumor. For endophytic tumors, their precise location and depth were evaluated with preoperative computed tomography images and intra-operative laparoscopic ultrasound (Tile-pro Ⓡ System).
Margins were then marked with monopolar cautery.
3) Robot-assisted tumor excision: Tumor resection was conducted under warm ischemia time. The renal artery and 
RESULTS
The operative parameters are summarized in Table 2 were comparable with those of current reports (Table 3) .
Although the cases were complex, warm ischemia time and estimated blood loss were similar to those of RLPN for general tumors. Operative time was also similar to other reports indicating no delay associated with the difficulty in resection and repair of complex renal tumors. There were also no intraoperative or postoperative complications observed.
For mean hospital stay, the lowest number of days was 1.5
[1] and our institution's experience was 4 days. The seemingly prolonged stay in our institution may be due to factors such as the health care system in Korea and patients' preference.
Although no emergency situations were encountered in this study, it is also important that a competent and experienced
bedside assistant is present who should be able to respond immediately when a situation requiring conversion to open surgery emerges. This is because the primary surgeon is in an unsterile condition at the console [7] . The use of robotic technology entails a higher cost, which has led to most renal tumors being treated via conventional laparoscopy or open surgery. However, RLPN may be offered in cases of complex renal tumors, especially for patients for whom nephron-sparing surgery is the only option.
CONCLUSIONS
RLPN is feasible and safe for complex renal tumors such as hilar and endophytic types. Because these types of surgeries implicate a high degree of difficulty, proper patient selection and adequate robotic surgery skills are advocated for a safe and successful surgery. Long-term studies should also be conducted to verify surgical and oncologic outcomes in the long run.
